Patents/Assignees

Halozyme, Inc.

31 patents in portfolio

US12600959utility2026
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12582713utility2026
Methods of Treating Tumors
0 cites
USD1118903design2026
Injection Device
0 cites
USD1118918design2026
Injector Cap
0 cites
US12558404utility2026
Hyaluronidase Enzyme Formulations for High Volume Administration
0 cites
US12551539utility2026
Hyaluronidase Enzyme Formulations for High Volume Administration
0 cites
US12544429utility2026
Hyaluronidase Enzyme Formulations for High Volume Administration
0 cites
USD1107901design2025
Injection Device
0 cites
USD1105416design2025
Injection Device
0 cites
USD1092725design2025
Injection Device
0 cites
US12371685utility2025
PH20 Polypeptide Variants with a Modification at Position 324 of the PH20 Polypeptide and a Method of Making Thereof
0 cites
US12264345utility2025
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12195773utility2025
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12178860utility2024
Hyaluronidase Enzyme Formulations for High Volume Administration
0 cites
US12152262utility2024
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12123035utility2024
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12110520utility2024
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12104184utility2024
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
US12104185utility2024
PH20 Polypeptide Variants, Formulations and Uses Thereof
0 cites
USD1042806design2024
Injection Device
0 cites

Page 1 of 2Next →